AMY PRUITT: Open Payments
NPI 1316190929 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 17 payments from 7 companies in 2025. Trend: 2023 $486 · 2024 $506 · 2025 $373
Food & beverage: $283Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $187 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $63 |
| Sage Therapeutics, LLC | 2 | $44 |
| Dexcom, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $17 |
Products named: Veozah, ZURZUVAE, Dexcom G6 Transmitter, Lynkuet, MYFEMBREE, SLYND.
Industry payments across OK — which companies pay providers there.
